Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Gerald Bryan Pier, PH.D.

TitleProfessor of Medicine (Microbiology and Molecular Genetics)
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressChanning Laboratory
181 Longwood Ave
Boston MA 02115
Phone617/525-2269
Fax617/525-2510

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Skurnik D, Roux D, Cattoir V, Danilchanka O, Lu X, Yoder-Himes DR, Han K, Guillard T, Jiang D, Gaultier C, Guerin F, Aschard H, Leclercq R, Mekalanos JJ, Lory S, Pier GB. Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing. Proc Natl Acad Sci U S A. 2013 Dec 17; 110(51):20747-52.
    View in: PubMed
  2. Skurnik D, Roux D, Aschard H, Cattoir V, Yoder-Himes D, Lory S, Pier GB. A Comprehensive Analysis of In Vitro and In Vivo Genetic Fitness of Pseudomonas aeruginosa Using High-Throughput Sequencing of Transposon Libraries. PLoS Pathog. 2013 Sep; 9(9):e1003582.
    View in: PubMed
  3. Zaidi T, Zaidi T, Yoong P, Pier GB. Staphylococcus aureus Corneal Infections: Effect of the Panton-Valentine Leukocidin (PVL) and Antibody to PVL on Virulence and Pathology. Invest Ophthalmol Vis Sci. 2013; 54(7):4430-8.
    View in: PubMed
  4. Pier GB. Will there ever be a universal Staphylococcus aureus vaccine? Hum Vaccin Immunother. 2013 Sep 1; 9(9):1865-76.
    View in: PubMed
  5. Cywes-Bentley C, Skurnik D, Zaidi T, Roux D, Deoliveira RB, Garrett WS, Lu X, O'Malley J, Kinzel K, Zaidi T, Rey A, Perrin C, Fichorova RN, Kayatani AK, Maira-Litràn T, Gening ML, Tsvetkov YE, Nifantiev NE, Bakaletz LO, Pelton SI, Golenbock DT, Pier GB. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens. Proc Natl Acad Sci U S A. 2013 Jun 11; 110(24):E2209-18.
    View in: PubMed
  6. França A, Vilanova M, Cerca N, Pier GB. Monoclonal Antibody Raised against PNAG Has Variable Effects on Static S. epidermidis Biofilm Accumulation In Vitro. Int J Biol Sci. 2013; 9(5):518-20.
    View in: PubMed
  7. Py BF, Gonzalez SF, Long K, Kim MS, Kim YA, Zhu H, Yao J, Degauque N, Villet R, Ymele-Leki P, Gadjeva M, Pier GB, Carroll MC, Yuan J. Cochlin produced by follicular dendritic cells promotes antibacterial innate immunity. Immunity. 2013 May 23; 38(5):1063-72.
    View in: PubMed
  8. Babra C, Tiwari JG, Pier G, Thein TH, Sunagar R, Sundareshan S, Isloor S, Hegde NR, de Wet S, Deighton M, Gibson J, Costantino P, Wetherall J, Mukkur T. The persistence of biofilm-associated antibiotic resistance of Staphylococcus aureus isolated from clinical bovine mastitis cases in Australia. Folia Microbiol (Praha). 2013 Nov; 58(6):469-74.
    View in: PubMed
  9. Søe NH, Jensen NV, Nürnberg BM, Jensen AL, Koch J, Poulsen SS, Pier G, Johansen HK. A novel knee prosthesis model of implant-related osteo- myelitis in rats. Acta Orthop. 2013 Feb; 84(1):92-7.
    View in: PubMed
  10. Reidy T, Rittenberg A, Dwyer M, D'Ortona S, Pier G, Gadjeva M. Homotrimeric Macrophage Migration Inhibitory Factor (MIF) Drives Inflammatory Responses in the Corneal Epithelium by Promoting Caveolin-rich Platform Assembly in Response to Infection. J Biol Chem. 2013 Mar 22; 288(12):8269-78.
    View in: PubMed
  11. Kamei A, Wu W, Traficante DC, Koh AY, Van Rooijen N, Pier GB, Priebe GP. Collaboration Between Macrophages and Vaccine-Induced CD4+ T Cells Confers Protection Against Lethal Pseudomonas aeruginosa Pneumonia During Neutropenia. J Infect Dis. 2013 Jan; 207(1):39-49.
    View in: PubMed
  12. Pozzi C, Wilk K, Lee JC, Gening M, Nifantiev N, Pier GB. Opsonic and Protective Properties of Antibodies Raised to Conjugate Vaccines Targeting Six Staphylococcus aureus Antigens. PLoS One. 2012; 7(10):e46648.
    View in: PubMed
  13. Tamang DL, Pirzai W, Priebe GP, Traficante DC, Pier GB, Falck JR, Morisseau C, Hammock BD, McCormick BA, Gronert K, Hurley BP. Hepoxilin a3 facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers. J Immunol. 2012 Nov 15; 189(10):4960-9.
    View in: PubMed
  14. Maira-Litrán T, Bentancor LV, Bozkurt-Guzel C, O'Malley JM, Cywes-Bentley C, Pier GB. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A. PLoS One. 2012; 7(9):e43813.
    View in: PubMed
  15. Roux D, Pier GB, Skurnik D. Magic bullets for the 21st century: the reemergence of immunotherapy for multi- and pan-resistant microbes. J Antimicrob Chemother. 2012 Dec; 67(12):2785-7.
    View in: PubMed
  16. Yoong P, Cywes-Bentley C, Pier GB. Poly-N-acetylglucosamine expression by wild-type Yersinia pestis is maximal at mammalian, not flea, temperatures. MBio. 2012; 3(4):e00217-12.
    View in: PubMed
  17. Komarova BS, Tsvetkov YE, Pier GB, Nifantiev NE. Synthesis of pentasaccharides corresponding to the glycoform II of the outer core region of the Pseudomonas aeruginosa lipopolysaccharide. Carbohydr Res. 2012 Oct 1; 360:56-68.
    View in: PubMed
  18. Bentancor LV, Routray A, Bozkurt-Guzel C, Camacho-Peiro A, Pier GB, Maira-Litrán T. Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections. Infect Immun. 2012 Oct; 80(10):3381-8.
    View in: PubMed
  19. Skurnik D, Kropec A, Roux D, Theilacker C, Huebner J, Pier GB. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy. Clin Infect Dis. 2012 Nov; 55(9):1188-97.
    View in: PubMed
  20. Zaidi TS, Zaidi T, Pier GB, Priebe GP. Topical neutralization of interleukin-17 during experimental Pseudomonas aeruginosa corneal infection promotes bacterial clearance and reduces pathology. Infect Immun. 2012 Oct; 80(10):3706-12.
    View in: PubMed
  21. Pier GB. The challenges and promises of new therapies for cystic fibrosis. J Exp Med. 2012 Jul 2; 209(7):1235-9.
    View in: PubMed
  22. Yoong P, Pier GB. Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. Infect Immun. 2012 Aug; 80(8):2894-904.
    View in: PubMed
  23. Bentancor LV, Camacho-Peiro A, Bozkurt-Guzel C, Pier GB, Maira-Litrán T. Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii. J Bacteriol. 2012 Aug; 194(15):3950-60.
    View in: PubMed
  24. Pozzi C, Waters EM, Rudkin JK, Schaeffer CR, Lohan AJ, Tong P, Loftus BJ, Pier GB, Fey PD, Massey RC, O'Gara JP. Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections. PLoS Pathog. 2012; 8(4):e1002626.
    View in: PubMed
  25. Skurnik D, Davis MR, Benedetti D, Moravec KL, Cywes-Bentley C, Roux D, Traficante DC, Walsh RL, Maira-Litràn T, Cassidy SK, Hermos CR, Martin TR, Thakkallapalli EL, Vargas SO, McAdam AJ, Lieberman TD, Kishony R, Lipuma JJ, Pier GB, Goldberg JB, Priebe GP. Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection. J Infect Dis. 2012 Jun; 205(11):1709-18.
    View in: PubMed
  26. Bentancor LV, O'Malley JM, Bozkurt-Guzel C, Pier GB, Maira-Litrán T. Poly-N-acetyl-ß-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect Immun. 2012 Feb; 80(2):651-6.
    View in: PubMed
  27. Lopez-Medina E, Neubauer MM, Pier GB, Koh AY. RNA isolation of Pseudomonas aeruginosa colonizing the murine gastrointestinal tract. J Vis Exp. 2011; (55).
    View in: PubMed
  28. Grachev AA, Gerbst AG, Gening ML, Titov DV, Yudina ON, Tsvetkov YE, Shashkov AS, Pier GB, Nifantiev NE. NMR and conformational studies of linear and cyclic oligo-(1?6)-ß-D-glucosamines. Carbohydr Res. 2011 Nov 8; 346(15):2499-510.
    View in: PubMed
  29. Zaidi T, Reidy T, D'Ortona S, Fichorova R, Pier G, Gadjeva M. CD74 deficiency ameliorates Pseudomonas aeruginosa-induced ocular infection. Sci Rep. 2011; 1:58.
    View in: PubMed
  30. Pier GB. Refers to: J.-P. Rasigade, N. Sicot, F. Laurent, G. Lina, F. Vandenesch, J. Etienne, A history of Panton-Valentine leukocidin (PVL)-associated infection protects against death in PVL-associated pneumonia, Vaccine 29 (25) (2011) 4185-4186. Vaccine. 2012 Mar 9; 30(12):2045-6.
    View in: PubMed
  31. Cerca F, Andrade F, França Â, Andrade EB, Ribeiro A, Almeida AA, Cerca N, Pier G, Azeredo J, Vilanova M. Staphylococcus epidermidis biofilms with higher proportions of dormant bacteria induce a lower activation of murine macrophages. J Med Microbiol. 2011 Dec; 60(Pt 12):1717-24.
    View in: PubMed
  32. Campodónico VL, Llosa NJ, Bentancor LV, Maira-Litran T, Pier GB. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice. Infect Immun. 2011 Aug; 79(8):3455-64.
    View in: PubMed
  33. Yudina ON, Gening ML, Tsvetkov YE, Grachev AA, Pier GB, Nifantiev NE. Synthesis of five nona-ß-(1?6)-d-glucosamines with various patterns of N-acetylation corresponding to the fragments of exopolysaccharide of Staphylococcus aureus. Carbohydr Res. 2011 May 15; 346(7):905-13.
    View in: PubMed
  34. Pier G, Prince A, Cantin A. Cystic fibrosis: an-ion transport issue? Nat Med. 2011 Feb; 17(2):166-7.
    View in: PubMed
  35. Kamei A, Coutinho-Sledge YS, Goldberg JB, Priebe GP, Pier GB. Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection. Infect Immun. 2011 Mar; 79(3):1289-99.
    View in: PubMed
  36. Koh AY, Mikkelsen PJ, Smith RS, Coggshall KT, Kamei A, Givskov M, Lory S, Pier GB. Utility of in vivo transcription profiling for identifying Pseudomonas aeruginosa genes needed for gastrointestinal colonization and dissemination. PLoS One. 2010; 5(12):e15131.
    View in: PubMed
  37. Hermos CR, Yoong P, Pier GB. High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection. Clin Infect Dis. 2010 Nov 15; 51(10):1138-46.
    View in: PubMed
  38. Skurnik D, Merighi M, Grout M, Gadjeva M, Maira-Litran T, Ericsson M, Goldmann DA, Huang SS, Datta R, Lee JC, Pier GB. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. J Clin Invest. 2010 Sep; 120(9):3220-33.
    View in: PubMed
  39. Levy H, Cannon CL, Asher D, García C, Cleveland RH, Pier GB, Knowles MR, Colin AA. Lack of correlation between pulmonary disease and cystic fibrosis transmembrane conductance regulator dysfunction in cystic fibrosis: a case report. J Med Case Rep. 2010; 4:117.
    View in: PubMed
  40. Ulrich M, Worlitzsch D, Viglio S, Siegmann N, Iadarola P, Shute JK, Geiser M, Pier GB, Friedel G, Barr ML, Schuster A, Meyer KC, Ratjen F, Bjarnsholt T, Gulbins E, Döring G. Alveolar inflammation in cystic fibrosis. J Cyst Fibros. 2010 May; 9(3):217-27.
    View in: PubMed
  41. Gadjeva M, Nagashima J, Zaidi T, Mitchell RA, Pier GB. Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis. PLoS Pathog. 2010 Mar; 6(3):e1000826.
    View in: PubMed
  42. Skurnik D, Ruimy R, Ready D, Ruppe E, Bernède-Bauduin C, Djossou F, Guillemot D, Pier GB, Andremont A. Is exposure to mercury a driving force for the carriage of antibiotic resistance genes? J Med Microbiol. 2010 Jul; 59(Pt 7):804-7.
    View in: PubMed
  43. Kallen R. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med. 2010 Feb 11; 362(6):555; author reply 556-7.
    View in: PubMed
  44. Skurnik D, Pier GB, Andremont A. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med. 2010 Feb 11; 362(6):555-6; author reply 556-7.
    View in: PubMed
  45. Yoong P, Pier GB. Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection. Proc Natl Acad Sci U S A. 2010 Feb 2; 107(5):2241-6.
    View in: PubMed
  46. Kamei A, Koh AY, Gadjeva M, Priebe GP, Lory S, Pier GB. Analysis of acquisition of Pseudomonas aeruginosa gastrointestinal mucosal colonization and horizontal transmission in a murine model. J Infect Dis. 2010 Jan 1; 201(1):71-80.
    View in: PubMed
  47. Campodónico VL, Llosa NJ, Grout M, Döring G, Maira-Litrán T, Pier GB. Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines. Infect Immun. 2010 Feb; 78(2):746-55.
    View in: PubMed
  48. Gadjeva M, Paradis-Bleau C, Priebe GP, Fichorova R, Pier GB. Caveolin-1 modifies the immunity to Pseudomonas aeruginosa. J Immunol. 2010 Jan 1; 184(1):296-302.
    View in: PubMed
  49. Gening ML, Maira-Litrán T, Kropec A, Skurnik D, Grout M, Tsvetkov YE, Nifantiev NE, Pier GB. Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infect Immun. 2010 Feb; 78(2):764-72.
    View in: PubMed
  50. Zaidi TS, Zaidi T, Pier GB. Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci. 2010 Apr; 51(4):2085-93.
    View in: PubMed
  51. Koh AY, Priebe GP, Ray C, Van Rooijen N, Pier GB. Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infect Immun. 2009 Dec; 77(12):5300-10.
    View in: PubMed
  52. Choi AH, Slamti L, Avci FY, Pier GB, Maira-Litrán T. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol. 2009 Oct; 191(19):5953-63.
    View in: PubMed
  53. Van Gennip M, Christensen LD, Alhede M, Phipps R, Jensen PØ, Christophersen L, Pamp SJ, Moser C, Mikkelsen PJ, Koh AY, Tolker-Nielsen T, Pier GB, Høiby N, Givskov M, Bjarnsholt T. Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes. APMIS. 2009 Jul; 117(7):537-46.
    View in: PubMed
  54. Levy H, Murphy A, Zou F, Gerard C, Klanderman B, Schuemann B, Lazarus R, García KC, Celedón JC, Drumm M, Dahmer M, Quasney M, Schneck K, Reske M, Knowles MR, Pier GB, Lange C, Weiss ST. IL1B polymorphisms modulate cystic fibrosis lung disease. Pediatr Pulmonol. 2009 Jun; 44(6):580-93.
    View in: PubMed
  55. Bajmoczi M, Gadjeva M, Alper SL, Pier GB, Golan DE. Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa. Am J Physiol Cell Physiol. 2009 Aug; 297(2):C263-77.
    View in: PubMed
  56. Feodorova VA, Pan'kina LN, Savostina EP, Kuznetsov OS, Konnov NP, Sayapina LV, Dentovskaya SV, Shaikhutdinova RZ, Ageev SA, Lindner B, Kondakova AN, Bystrova OV, Kocharova NA, Senchenkova SN, Holst O, Pier GB, Knirel YA, Anisimov AP, Motin VL. Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens. Vaccine. 2009 Apr 6; 27(16):2240-50.
    View in: PubMed
  57. Pérez MM, Prenafeta A, Valle J, Penadés J, Rota C, Solano C, Marco J, Grilló MJ, Lasa I, Irache JM, Maira-Litran T, Jiménez-Barbero J, Costa L, Pier GB, de Andrés D, Amorena B. Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl beta-1,6 glucosamine specific antibody production using biofilm-embedded bacteria. Vaccine. 2009 Apr 14; 27(17):2379-86.
    View in: PubMed
  58. Pier GB. On the greatly exaggerated reports of the death of infectious diseases. Clin Infect Dis. 2008 Oct 15; 47(8):1113-4.
    View in: PubMed
  59. Komarova BS, Tsvetkov YE, Pier GB, Nifantiev NE. First synthesis of pentasaccharide glycoform I of the outer core region of the Pseudomonas aeruginosa lipopolysaccharide. J Org Chem. 2008 Nov 7; 73(21):8411-21.
    View in: PubMed
  60. Priebe GP, Walsh RL, Cederroth TA, Kamei A, Coutinho-Sledge YS, Goldberg JB, Pier GB. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa. J Immunol. 2008 Oct 1; 181(7):4965-75.
    View in: PubMed
  61. Zaidi T, Pier GB. Prophylactic and therapeutic efficacy of a fully human immunoglobulin G1 monoclonal antibody to Pseudomonas aeruginosa alginate in murine keratitis infection. Infect Immun. 2008 Oct; 76(10):4720-5.
    View in: PubMed
  62. Qiu D, Eisinger VM, Head NE, Pier GB, Yu HD. ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa. Microbiology. 2008 Jul; 154(Pt 7):2119-30.
    View in: PubMed
  63. Levy H, Kalish LA, Cannon CL, García KC, Gerard C, Goldmann D, Pier GB, Weiss ST, Colin AA. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients. Pediatr Pulmonol. 2008 May; 43(5):463-71.
    View in: PubMed
  64. Pier GB. Dropping acid to help cystic fibrosis. Nat Med. 2008 Apr; 14(4):367-9.
    View in: PubMed
  65. Zaidi T, Bajmoczi M, Zaidi T, Golan DE, Pier GB. Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci. 2008 Mar; 49(3):1000-9.
    View in: PubMed
  66. Vergara-Irigaray M, Maira-Litrán T, Merino N, Pier GB, Penadés JR, Lasa I. Wall teichoic acids are dispensable for anchoring the PNAG exopolysaccharide to the Staphylococcus aureus cell surface. Microbiology. 2008 Mar; 154(Pt 3):865-77.
    View in: PubMed
  67. Campodónico VL, Gadjeva M, Paradis-Bleau C, Uluer A, Pier GB. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Trends Mol Med. 2008 Mar; 14(3):120-33.
    View in: PubMed
  68. Koh AY, Köhler JR, Coggshall KT, Van Rooijen N, Pier GB. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog. 2008 Feb 8; 4(2):e35.
    View in: PubMed
  69. Döring G, Pier GB. Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine. 2008 Feb 20; 26(8):1011-24.
    View in: PubMed
  70. Feodorova VA, Pan'kina LN, Savostina EP, Sayapina LV, Motin VL, Dentovskaya SV, Shaikhutdinova RZ, Ivanov SA, Lindner B, Kondakova AN, Bystrova OV, Kocharova NA, Senchenkova SN, Holst O, Pier GB, Knirel YA, Anisimov AP. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs. Vaccine. 2007 Nov 1; 25(44):7620-8.
    View in: PubMed
  71. Kowalski MP, Dubouix-Bourandy A, Bajmoczi M, Golan DE, Zaidi T, Coutinho-Sledge YS, Gygi MP, Gygi SP, Wiemer EA, Pier GB. Host resistance to lung infection mediated by major vault protein in epithelial cells. Science. 2007 Jul 6; 317(5834):130-2.
    View in: PubMed
  72. Cerca N, Jefferson KK, Maira-Litrán T, Pier DB, Kelly-Quintos C, Goldmann DA, Azeredo J, Pier GB. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun. 2007 Jul; 75(7):3406-13.
    View in: PubMed
  73. Pier GB. Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. Int J Med Microbiol. 2007 Sep; 297(5):277-95.
    View in: PubMed
  74. Cerca N, Maira-Litrán T, Jefferson KK, Grout M, Goldmann DA, Pier GB. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide. Proc Natl Acad Sci U S A. 2007 May 1; 104(18):7528-33.
    View in: PubMed
  75. Anisimov AP, Shaikhutdinova RZ, Pan'kina LN, Feodorova VA, Savostina EP, Bystrova OV, Lindner B, Mokrievich AN, Bakhteeva IV, Titareva GM, Dentovskaya SV, Kocharova NA, Senchenkova SN, Holst O, Devdariani ZL, Popov YA, Pier GB, Knirel YA. Effect of deletion of the lpxM gene on virulence and vaccine potential of Yersinia pestis in mice. J Med Microbiol. 2007 Apr; 56(Pt 4):443-53.
    View in: PubMed
  76. Pier GB. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines? Hum Vaccin. 2007 Mar-Apr; 3(2):39-40; author reply 41.
    View in: PubMed
  77. DiGiandomenico A, Rao J, Harcher K, Zaidi TS, Gardner J, Neely AN, Pier GB, Goldberg JB. Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections. Proc Natl Acad Sci U S A. 2007 Mar 13; 104(11):4624-9.
    View in: PubMed
  78. Levy H, Kalish LA, Huntington I, Weller N, Gerard C, Silverman EK, Celedón JC, Pier GB, Weiss ST. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol. 2007 Mar; 42(3):256-62.
    View in: PubMed
  79. Reiniger N, Lee MM, Coleman FT, Ray C, Golan DE, Pier GB. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect Immun. 2007 Apr; 75(4):1598-608.
    View in: PubMed
  80. Knirel YA, Dentovskaya SV, Bystrova OV, Kocharova NA, Senchenkova SN, Shaikhutdinova RZ, Titareva GM, Bakhteeva IV, Lindner B, Pier GB, Anisimov AP. Relationship of the lipopolysaccharide structure of Yersinia pestis to resistance to antimicrobial factors. Adv Exp Med Biol. 2007; 603:88-96.
    View in: PubMed
  81. Pier GB. Airway epithelial (nasal) cell monolayers used to study Pseudomonas aeruginosa invasion are hyperpolarized and not representative of the human airway epithelium. Infect Immun. 2006 Dec; 74(12):7043; author reply 7043-4.
    View in: PubMed
  82. Gening ML, Tsvetkov YE, Pier GB, Nifantiev NE. Synthesis of beta-(1-->6)-linked glucosamine oligosaccharides corresponding to fragments of the bacterial surface polysaccharide poly-N-acetylglucosamine. Carbohydr Res. 2007 Feb 26; 342(3-4):567-75.
    View in: PubMed
  83. Cerca N, Jefferson KK, Oliveira R, Pier GB, Azeredo J. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun. 2006 Aug; 74(8):4849-55.
    View in: PubMed
  84. Gening ML, Tsvetkov IuE, Pier GB, Nifant'ev NE. [The study of the reaction of terminated oligomerization in the synthesis of oligo-(beta1-6)-glucosamines]. Bioorg Khim. 2006 Jul-Aug; 32(4):432-43.
    View in: PubMed
  85. Kelly-Quintos C, Cavacini LA, Posner MR, Goldmann D, Pier GB. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infect Immun. 2006 May; 74(5):2742-50.
    View in: PubMed
  86. Zaidi TS, Priebe GP, Pier GB. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection. Infect Immun. 2006 Feb; 74(2):975-83.
    View in: PubMed
  87. Bystrova OV, Knirel YA, Lindner B, Kocharova NA, Kondakova AN, Zähringer U, Pier GB. Structures of the core oligosaccharide and O-units in the R- and SR-type lipopolysaccharides of reference strains of Pseudomonas aeruginosa O-serogroups. FEMS Immunol Med Microbiol. 2006 Feb; 46(1):85-99.
    View in: PubMed
  88. Knirel YA, Bystrova OV, Kocharova NA, Zähringer U, Pier GB. Conserved and variable structural features in the lipopolysaccharide of Pseudomonas aeruginosa. J Endotoxin Res. 2006; 12(6):324-36.
    View in: PubMed
  89. Cerca N, Martins S, Sillankorva S, Jefferson KK, Pier GB, Oliveira R, Azeredo J. Effects of growth in the presence of subinhibitory concentrations of dicloxacillin on Staphylococcus epidermidis and Staphylococcus haemolyticus biofilms. Appl Environ Microbiol. 2005 Dec; 71(12):8677-82.
    View in: PubMed
  90. Kelly-Quintos C, Kropec A, Briggs S, Ordonez CL, Goldmann DA, Pier GB. The role of epitope specificity in the human opsonic antibody response to the staphylococcal surface polysaccharide poly N-acetyl glucosamine. J Infect Dis. 2005 Dec 1; 192(11):2012-9.
    View in: PubMed
  91. Anisimov AP, Dentovskaya SV, Titareva GM, Bakhteeva IV, Shaikhutdinova RZ, Balakhonov SV, Lindner B, Kocharova NA, Senchenkova SN, Holst O, Pier GB, Knirel YA. Intraspecies and temperature-dependent variations in susceptibility of Yersinia pestis to the bactericidal action of serum and to polymyxin B. Infect Immun. 2005 Nov; 73(11):7324-31.
    View in: PubMed
  92. Maira-Litrán T, Kropec A, Goldmann DA, Pier GB. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun. 2005 Oct; 73(10):6752-62.
    View in: PubMed
  93. Kropec A, Maira-Litran T, Jefferson KK, Grout M, Cramton SE, Götz F, Goldmann DA, Pier GB. Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection. Infect Immun. 2005 Oct; 73(10):6868-76.
    View in: PubMed
  94. Pier G. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections. Expert Rev Vaccines. 2005 Oct; 4(5):645-56.
    View in: PubMed
  95. Reiniger N, Ichikawa JK, Pier GB. Influence of cystic fibrosis transmembrane conductance regulator on gene expression in response to Pseudomonas aeruginosa infection of human bronchial epithelial cells. Infect Immun. 2005 Oct; 73(10):6822-30.
    View in: PubMed
  96. Knirel YA, Lindner B, Vinogradov E, Shaikhutdinova RZ, Senchenkova SN, Kocharova NA, Holst O, Pier GB, Anisimov AP. Cold temperature-induced modifications to the composition and structure of the lipopolysaccharide of Yersinia pestis. Carbohydr Res. 2005 Jul 4; 340(9):1625-30.
    View in: PubMed
  97. Bragonzi A, Worlitzsch D, Pier GB, Timpert P, Ulrich M, Hentzer M, Andersen JB, Givskov M, Conese M, Doring G. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. J Infect Dis. 2005 Aug 1; 192(3):410-9.
    View in: PubMed
  98. Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, Oliveira R, Azeredo J. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother. 2005 Aug; 56(2):331-6.
    View in: PubMed
  99. Jefferson KK, Goldmann DA, Pier GB. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 2005 Jun; 49(6):2467-73.
    View in: PubMed
  100. Lai Z, Kimmel R, Petersen S, Thomas S, Pier G, Bezabeh B, Luo R, Schreiber JR. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes. Vaccine. 2005 May 9; 23(25):3264-71.
    View in: PubMed
  101. Koh AY, Priebe GP, Pier GB. Virulence of Pseudomonas aeruginosa in a murine model of gastrointestinal colonization and dissemination in neutropenia. Infect Immun. 2005 Apr; 73(4):2262-72.
    View in: PubMed
  102. Cerca N, Martins S, Pier GB, Oliveira R, Azeredo J. The relationship between inhibition of bacterial adhesion to a solid surface by sub-MICs of antibiotics and subsequent development of a biofilm. Res Microbiol. 2005 Jun-Jul; 156(5-6):650-5.
    View in: PubMed
  103. Cerca N, Pier GB, Vilanova M, Oliveira R, Azeredo J. Quantitative analysis of adhesion and biofilm formation on hydrophilic and hydrophobic surfaces of clinical isolates of Staphylococcus epidermidis. Res Microbiol. 2005 May; 156(4):506-14.
    View in: PubMed
  104. Knirel YA, Lindner B, Vinogradov EV, Kocharova NA, Senchenkova SN, Shaikhutdinova RZ, Dentovskaya SV, Fursova NK, Bakhteeva IV, Titareva GM, Balakhonov SV, Holst O, Gremyakova TA, Pier GB, Anisimov AP. Temperature-dependent variations and intraspecies diversity of the structure of the lipopolysaccharide of Yersinia pestis. Biochemistry. 2005 Feb 8; 44(5):1731-43.
    View in: PubMed
  105. Pier GB, Boyer D, Preston M, Coleman FT, Llosa N, Mueschenborn-Koglin S, Theilacker C, Goldenberg H, Uchin J, Priebe GP, Grout M, Posner M, Cavacini L. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J Immunol. 2004 Nov 1; 173(9):5671-8.
    View in: PubMed
  106. Cerca N, Pier GB, Oliveira R, Azeredo J. Comparative evaluation of coagulase-negative staphylococci (CoNS) adherence to acrylic by a static method and a parallel-plate flow dynamic method. Res Microbiol. 2004 Nov; 155(9):755-60.
    View in: PubMed
  107. Zaidi T, Mowrey-McKee M, Pier GB. Hypoxia increases corneal cell expression of CFTR leading to increased Pseudomonas aeruginosa binding, internalization, and initiation of inflammation. Invest Ophthalmol Vis Sci. 2004 Nov; 45(11):4066-74.
    View in: PubMed
  108. Priebe GP, Dean CR, Zaidi T, Meluleni GJ, Coleman FT, Coutinho YS, Noto MJ, Urban TA, Pier GB, Goldberg JB. The galU Gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung. Infect Immun. 2004 Jul; 72(7):4224-32.
    View in: PubMed
  109. Jefferson KK, Pier DB, Goldmann DA, Pier GB. The teicoplanin-associated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus. J Bacteriol. 2004 Apr; 186(8):2449-56.
    View in: PubMed
  110. Anisimov AP, Lindler LE, Pier GB. Intraspecific diversity of Yersinia pestis. Clin Microbiol Rev. 2004 Apr; 17(2):434-64.
    View in: PubMed
  111. Maira-Litran T, Kropec A, Goldmann D, Pier GB. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide. Vaccine. 2004 Feb 17; 22(7):872-9.
    View in: PubMed
  112. Walker RI, Blanchard T, Braun JM, Cebra JJ, Cross AS, Fattom A, Giannasca PJ, Holder IA, Huebner J, Matthews R, Pier GB, Romani L, von Specht BU, Trautmann M. Meeting summary: possibilities for active and passive vaccination against opportunistic infections. Vaccine. 2004 Feb 17; 22(7):801-4.
    View in: PubMed
  113. Bystrova OV, Lindner B, Moll H, Kocharova NA, Knirel YA, Zahringer U, Pier GB. Full structure of the lipopolysaccharide of Pseudomonas aeruginosa immunotype 5. Biochemistry (Mosc). 2004 Feb; 69(2):170-5.
    View in: PubMed
  114. Krueger WA, Krueger-Rameck S, Koch S, Carey V, Pier GB, Huebner J. Assessment of the role of antibiotics and enterococcal virulence factors in a mouse model of extraintestinal translocation. Crit Care Med. 2004 Feb; 32(2):467-71.
    View in: PubMed
  115. Kowalski MP, Pier GB. Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. J Immunol. 2004 Jan 1; 172(1):418-25.
    View in: PubMed
  116. Cerca N, Pier GB, Vilanova M, Oliveira R, Azeredo J. Influence of batch or fed-batch growth on Staphylococcus epidermidis biofilm formation. Lett Appl Microbiol. 2004; 39(5):420-4.
    View in: PubMed
  117. Cabrol S, Olliver A, Pier GB, Andremont A, Ruimy R. Transcription of quorum-sensing system genes in clinical and environmental isolates of Pseudomonas aeruginosa. J Bacteriol. 2003 Dec; 185(24):7222-30.
    View in: PubMed
  118. Pier GB. Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen. Carbohydr Res. 2003 Nov 14; 338(23):2549-56.
    View in: PubMed
  119. Bystrova OV, Lindner B, Moll H, Kocharova NA, Knirel YA, Zähringer U, Pier GB. Structure of the lipopolysaccharide of Pseudomonas aeruginosa O-12 with a randomly O-acetylated core region. Carbohydr Res. 2003 Sep 1; 338(18):1895-905.
    View in: PubMed
  120. Ullrich S, Berchtold S, Boehmer C, Fillon S, Jendrossek V, Palmada M, Schroeder TH, Pier GB, Lang F. Pseudomonas aeruginosa activates Cl- channels in host epithelial cells. Pflugers Arch. 2003 Oct; 447(1):23-8.
    View in: PubMed
  121. Bystrova OV, Lindner B, Moll H, Kocharova NA, Knirel YA, Zähringer U, Pier GB. Structure of the biological repeating unit of the O-antigen of Pseudomonas aeruginosa immunotype 4 containing both 2-acetamido-2,6-dideoxy-D-glucose and 2-acetamido-2,6-dideoxy-D-galactose. Carbohydr Res. 2003 Aug 12; 338(17):1801-6.
    View in: PubMed
  122. Bystrova OV, Shashkov AS, Kocharova NA, Knirel YA, Zähringer U, Pier GB. Elucidation of the structure of the lipopolysaccharide core and the linkage between the core and the O-antigen in Pseudomonas aeruginosa immunotype 5 using strong alkaline degradation of the lipopolysaccharide. Biochemistry (Mosc). 2003 Aug; 68(8):918-25.
    View in: PubMed
  123. Cannon CL, Kowalski MP, Stopak KS, Pier GB. Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. Am J Respir Cell Mol Biol. 2003 Aug; 29(2):188-97.
    View in: PubMed
  124. Theilacker C, Coleman FT, Mueschenborn S, Llosa N, Grout M, Pier GB. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. Infect Immun. 2003 Jul; 71(7):3875-84.
    View in: PubMed
  125. Jefferson KK, Cramton SE, Götz F, Pier GB. Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA-binding properties of IcaR. Mol Microbiol. 2003 May; 48(4):889-99.
    View in: PubMed
  126. Joyce JG, Abeygunawardana C, Xu Q, Cook JC, Hepler R, Przysiecki CT, Grimm KM, Roper K, Ip CC, Cope L, Montgomery D, Chang M, Campie S, Brown M, McNeely TB, Zorman J, Maira-Litrán T, Pier GB, Keller PM, Jansen KU, Mark GE. Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus. Carbohydr Res. 2003 Apr 22; 338(9):903-22.
    View in: PubMed
  127. Priebe GP, Meluleni GJ, Coleman FT, Goldberg JB, Pier GB. Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant. Infect Immun. 2003 Mar; 71(3):1453-61.
    View in: PubMed
  128. Coleman FT, Mueschenborn S, Meluleni G, Ray C, Carey VJ, Vargas SO, Cannon CL, Ausubel FM, Pier GB. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. Proc Natl Acad Sci U S A. 2003 Feb 18; 100(4):1949-54.
    View in: PubMed
  129. Lyczak JB, Pier GB. Salmonella enterica serovar typhi modulates cell surface expression of its receptor, the cystic fibrosis transmembrane conductance regulator, on the intestinal epithelium. Infect Immun. 2002 Nov; 70(11):6416-23.
    View in: PubMed
  130. Maira-Litrán T, Kropec A, Abeygunawardana C, Joyce J, Mark G, Goldmann DA, Pier GB. Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect Immun. 2002 Aug; 70(8):4433-40.
    View in: PubMed
  131. Schroeder TH, Lee MM, Yacono PW, Cannon CL, Gerçeker AA, Golan DE, Pier GB. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. Proc Natl Acad Sci U S A. 2002 May 14; 99(10):6907-12.
    View in: PubMed
  132. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2002 Apr; 15(2):194-222.
    View in: PubMed
  133. Bystrova OV, Shashkov AS, Kocharova NA, Knirel YA, Lindner B, Zähringer U, Pier GB. Structural studies on the core and the O-polysaccharide repeating unit of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide. Eur J Biochem. 2002 Apr; 269(8):2194-203.
    View in: PubMed
  134. Priebe GP, Brinig MM, Hatano K, Grout M, Coleman FT, Pier GB, Goldberg JB. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine. Infect Immun. 2002 Mar; 70(3):1507-17.
    View in: PubMed
  135. Pier GB. CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection. Curr Opin Microbiol. 2002 Feb; 5(1):81-6.
    View in: PubMed
  136. Lyczak JB, Zaidi TS, Grout M, Bittner M, Contreras I, Pier GB. Epithelial cell contact-induced alterations in Salmonella enterica serovar Typhi lipopolysaccharide are critical for bacterial internalization. Cell Microbiol. 2001 Nov; 3(11):763-72.
    View in: PubMed
  137. Knirel YA, Bystrova OV, Shashkov AS, Lindner B, Kocharova NA, Senchenkova SN, Moll H, Zähringer U, Hatano K, Pier GB. Structural analysis of the lipopolysaccharide core of a rough, cystic fibrosis isolate of Pseudomonas aeruginosa. Eur J Biochem. 2001 Sep; 268(17):4708-19.
    View in: PubMed
  138. Schroeder TH, Reiniger N, Meluleni G, Grout M, Coleman FT, Pier GB. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract. J Immunol. 2001 Jun 15; 166(12):7410-8.
    View in: PubMed
  139. Park PW, Pier GB, Hinkes MT, Bernfield M. Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature. 2001 May 3; 411(6833):98-102.
    View in: PubMed
  140. Hemachandra S, Kamboj K, Copfer J, Pier G, Green LL, Schreiber JR. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis. Infect Immun. 2001 Apr; 69(4):2223-9.
    View in: PubMed
  141. Pier GB, Coleman F, Grout M, Franklin M, Ohman DE. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Infect Immun. 2001 Mar; 69(3):1895-901.
    View in: PubMed
  142. Schroeder TH, Zaidi T, Pier GB. Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM(1) on epithelial cells. Infect Immun. 2001 Feb; 69(2):719-29.
    View in: PubMed
  143. Goldberg JB, Pier GB. The role of the CFTR in susceptibility to Pseudomonas aeruginosa infections in cystic fibrosis. Trends Microbiol. 2000 Nov; 8(11):514-20.
    View in: PubMed
  144. Mckenney D, Pouliot K, Wang Y, Murthy V, Ulrich M, Döring G, Lee JC, Goldmann DA, Pier GB. Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J Biotechnol. 2000 Sep 29; 83(1-2):37-44.
    View in: PubMed
  145. Pier GB. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. Proc Natl Acad Sci U S A. 2000 Aug 1; 97(16):8822-8.
    View in: PubMed
  146. Huebner J, Quaas A, Krueger WA, Goldmann DA, Pier GB. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Infect Immun. 2000 Aug; 68(8):4631-6.
    View in: PubMed
  147. Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2000 Jul; 2(9):1051-60.
    View in: PubMed
  148. Allewelt M, Coleman FT, Grout M, Priebe GP, Pier GB. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect Immun. 2000 Jul; 68(7):3998-4004.
    View in: PubMed
  149. Pier GB. Peptides, Pseudomonas aeruginosa, polysaccharides and lipopolysaccharides--players in the predicament of cystic fibrosis patients. Trends Microbiol. 2000 Jun; 8(6):247-50; discussion 250-1.
    View in: PubMed
  150. Park PW, Pier GB, Preston MJ, Goldberger O, Fitzgerald ML, Bernfield M. Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa. J Biol Chem. 2000 Feb 4; 275(5):3057-64.
    View in: PubMed
  151. Gerçeker AA, Zaidi T, Marks P, Golan DE, Pier GB. Impact of heterogeneity within cultured cells on bacterial invasion: analysis of Pseudomonas aeruginosa and Salmonella enterica serovar typhi entry into MDCK cells by using a green fluorescent protein-labelled cystic fibrosis transmembrane conductance regulator receptor. Infect Immun. 2000 Feb; 68(2):861-70.
    View in: PubMed
  152. Parad RB, Gerard CJ, Zurakowski D, Nichols DP, Pier GB. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect Immun. 1999 Sep; 67(9):4744-50.
    View in: PubMed
  153. Dean CR, Franklund CV, Retief JD, Coyne MJ, Hatano K, Evans DJ, Pier GB, Goldberg JB. Characterization of the serogroup O11 O-antigen locus of Pseudomonas aeruginosa PA103. J Bacteriol. 1999 Jul; 181(14):4275-84.
    View in: PubMed
  154. McKenney D, Pouliot KL, Wang Y, Murthy V, Ulrich M, Döring G, Lee JC, Goldmann DA, Pier GB. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science. 1999 May 28; 284(5419):1523-7.
    View in: PubMed
  155. Wang Y, Huebner J, Tzianabos AO, Martirosian G, Kasper DL, Pier GB. Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Carbohydr Res. 1999 Mar 31; 316(1-4):155-60.
    View in: PubMed
  156. Huebner J, Wang Y, Krueger WA, Madoff LC, Martirosian G, Boisot S, Goldmann DA, Kasper DL, Tzianabos AO, Pier GB. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect Immun. 1999 Mar; 67(3):1213-9.
    View in: PubMed
  157. Zaidi TS, Lyczak J, Preston M, Pier GB. Cystic fibrosis transmembrane conductance regulator-mediated corneal epithelial cell ingestion of Pseudomonas aeruginosa is a key component in the pathogenesis of experimental murine keratitis. Infect Immun. 1999 Mar; 67(3):1481-92.
    View in: PubMed
  158. McKenney D, Hübner J, Muller E, Wang Y, Goldmann DA, Pier GB. The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun. 1998 Oct; 66(10):4711-20.
    View in: PubMed
  159. Preston MJ, Gerçeker AA, Reff ME, Pier GB. Production and characterization of a set of mouse-human chimeric immunoglobulin G (IgG) subclass and IgA monoclonal antibodies with identical variable regions specific for Pseudomonas aeruginosa serogroup O6 lipopolysaccharide. Infect Immun. 1998 Sep; 66(9):4137-42.
    View in: PubMed
  160. Hatano K, Pier GB. Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains. Infect Immun. 1998 Aug; 66(8):3719-26.
    View in: PubMed
  161. Pier GB, Grout M, Zaidi T, Meluleni G, Mueschenborn SS, Banting G, Ratcliff R, Evans MJ, Colledge WH. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature. 1998 May 7; 393(6680):79-82.
    View in: PubMed
  162. Pier GB, Grout M, Zaidi TS. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci U S A. 1997 Oct 28; 94(22):12088-93.
    View in: PubMed
  163. Preston MJ, Seed PC, Toder DS, Iglewski BH, Ohman DE, Gustin JK, Goldberg JB, Pier GB. Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections. Infect Immun. 1997 Aug; 65(8):3086-90.
    View in: PubMed
  164. Preston MJ, Gerçeker AA, Koles NL, Pollack M, Pier GB. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Invest Ophthalmol Vis Sci. 1997 Jun; 38(7):1418-25.
    View in: PubMed
  165. Zaidi TS, Preston MJ, Pier GB. Inhibition of bacterial adherence to host tissue does not markedly affect disease in the murine model of Pseudomonas aeruginosa corneal infection. Infect Immun. 1997 Apr; 65(4):1370-6.
    View in: PubMed
  166. Pier GB. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients. Behring Inst Mitt. 1997 Feb; (98):350-60.
    View in: PubMed
  167. Pier GB, Grout M, Zaidi TS, Goldberg JB. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis. Am J Respir Crit Care Med. 1996 Oct; 154(4 Pt 2):S175-82.
    View in: PubMed
  168. Fleiszig SM, Evans DJ, Mowrey-McKee MF, Payor R, Zaidi TS, Vallas V, Muller E, Pier GB. Factors affecting Staphylococcus epidermidis adhesion to contact lenses. Optom Vis Sci. 1996 Sep; 73(9):590-4.
    View in: PubMed
  169. Fleiszig SM, Zaidi TS, Preston MJ, Grout M, Evans DJ, Pier GB. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun. 1996 Jun; 64(6):2288-94.
    View in: PubMed
  170. Zaidi TS, Fleiszig SM, Preston MJ, Goldberg JB, Pier GB. Lipopolysaccharide outer core is a ligand for corneal cell binding and ingestion of Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci. 1996 May; 37(6):976-86.
    View in: PubMed
  171. Pier GB. Analysis of naturally occurring antibodies to mucoid Pseudomonas aeruginosa in cystic fibrosis patients. J Infect Dis. 1996 Feb; 173(2):513-5.
    View in: PubMed
  172. Pier GB, Grout M, Zaidi TS, Olsen JC, Johnson LG, Yankaskas JR, Goldberg JB. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science. 1996 Jan 5; 271(5245):64-7.
    View in: PubMed
  173. Pier GB, Goldberg JB. Pseudomonas aeruginosa A-band and B-band lipopolysaccharides. Infect Immun. 1995 Dec; 63(12):4964-5.
    View in: PubMed
  174. Shiro H, Meluleni G, Groll A, Muller E, Tosteson TD, Goldmann DA, Pier GB. The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis. Circulation. 1995 Nov 1; 92(9):2715-22.
    View in: PubMed
  175. Pollack M, Koles NL, Preston MJ, Brown BJ, Pier GB. Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide. Infect Immun. 1995 Nov; 63(11):4481-8.
    View in: PubMed
  176. Fleiszig SM, Zaidi TS, Pier GB. Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro. Infect Immun. 1995 Oct; 63(10):4072-7.
    View in: PubMed
  177. Preston MJ, Fleiszig SM, Zaidi TS, Goldberg JB, Shortridge VD, Vasil ML, Pier GB. Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice. Infect Immun. 1995 Sep; 63(9):3497-501.
    View in: PubMed
  178. Meluleni GJ, Grout M, Evans DJ, Pier GB. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. J Immunol. 1995 Aug 15; 155(4):2029-38.
    View in: PubMed
  179. Pier GB, Meluleni G, Goldberg JB. Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies. Infect Immun. 1995 Aug; 63(8):2818-25.
    View in: PubMed
  180. Shiro H, Muller E, Takeda S, Tosteson TD, Goldmann DA, Pier GB. Potentiation of Staphylococcus epidermidis catheter-related bacteremia by lipid infusions. J Infect Dis. 1995 Jan; 171(1):220-4.
    View in: PubMed
  181. Hatano K, Goldberg JB, Pier GB. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate). Infect Immun. 1995 Jan; 63(1):21-6.
    View in: PubMed
  182. Pier GB, DesJardin D, Grout M, Garner C, Bennett SE, Pekoe G, Fuller SA, Thornton MO, Harkonen WS, Miller HC. Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine. Infect Immun. 1994 Sep; 62(9):3972-9.
    View in: PubMed
  183. Hatano K, Boisot S, DesJardins D, Wright DC, Brisker J, Pier GB. Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa. Infect Immun. 1994 Sep; 62(9):3608-16.
    View in: PubMed
  184. Fleiszig SM, Zaidi TS, Fletcher EL, Preston MJ, Pier GB. Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infect Immun. 1994 Aug; 62(8):3485-93.
    View in: PubMed
  185. Evans DJ, Pier GB, Coyne MJ, Goldberg JB. The rfb locus from Pseudomonas aeruginosa strain PA103 promotes the expression of O antigen by both LPS-rough and LPS-smooth isolates from cystic fibrosis patients. Mol Microbiol. 1994 Aug; 13(3):427-34.
    View in: PubMed
  186. Shiro H, Muller E, Gutierrez N, Boisot S, Grout M, Tosteson TD, Goldmann D, Pier GB. Transposon mutants of Staphylococcus epidermidis deficient in elaboration of capsular polysaccharide/adhesin and slime are avirulent in a rabbit model of endocarditis. J Infect Dis. 1994 May; 169(5):1042-9.
    View in: PubMed
  187. Fleiszig SM, Zaidi TS, Ramphal R, Pier GB. Modulation of Pseudomonas aeruginosa adherence to the corneal surface by mucus. Infect Immun. 1994 May; 62(5):1799-804.
    View in: PubMed
  188. Pier GB, Koles NL, Meluleni G, Hatano K, Pollack M. Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06. Infect Immun. 1994 Apr; 62(4):1137-43.
    View in: PubMed
  189. Huebner J, Pier GB, Maslow JN, Muller E, Shiro H, Parent M, Kropec A, Arbeit RD, Goldmann DA. Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years. J Infect Dis. 1994 Mar; 169(3):526-31.
    View in: PubMed
  190. Fleiszig SM, Zaidi TS, Pier GB. Mucus and Pseudomonas aeruginosa adherence to the cornea. Adv Exp Med Biol. 1994; 350:359-62.
    View in: PubMed
  191. Muller E, Takeda S, Shiro H, Goldmann D, Pier GB. Occurrence of capsular polysaccharide/adhesin among clinical isolates of coagulase-negative staphylococci. J Infect Dis. 1993 Nov; 168(5):1211-8.
    View in: PubMed
  192. Mai GT, McCormack JG, Seow WK, Pier GB, Jackson LA, Thong YH. Inhibition of adherence of mucoid Pseudomonas aeruginosa by alginase, specific monoclonal antibodies, and antibiotics. Infect Immun. 1993 Oct; 61(10):4338-43.
    View in: PubMed
  193. Pittet JF, Matthay MA, Pier G, Grady M, Wiener-Kronish JP. Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody. J Clin Invest. 1993 Sep; 92(3):1221-8.
    View in: PubMed
  194. Hatano K, Goldberg JB, Pier GB. Pseudomonas aeruginosa lipopolysaccharide: evidence that the O side chains and common antigens are on the same molecule. J Bacteriol. 1993 Aug; 175(16):5117-28.
    View in: PubMed
  195. Goldmann DA, Pier GB. Pathogenesis of infections related to intravascular catheterization. Clin Microbiol Rev. 1993 Apr; 6(2):176-92.
    View in: PubMed
  196. Goldberg JB, Hatano K, Pier GB. Synthesis of lipopolysaccharide O side chains by Pseudomonas aeruginosa PAO1 requires the enzyme phosphomannomutase. J Bacteriol. 1993 Mar; 175(6):1605-11.
    View in: PubMed
  197. Pier GB, Takeda S, Grout M, Markham RB. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa. J Clin Invest. 1993 Mar; 91(3):1079-87.
    View in: PubMed
  198. Mai GT, Seow WK, Pier GB, McCormack JG, Thong YH. Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments. Infect Immun. 1993 Feb; 61(2):559-64.
    View in: PubMed
  199. Muller E, Hübner J, Gutierrez N, Takeda S, Goldmann DA, Pier GB. Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect Immun. 1993 Feb; 61(2):551-8.
    View in: PubMed
  200. Goldberg JB, Hatano K, Meluleni GS, Pier GB. Cloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli. Proc Natl Acad Sci U S A. 1992 Nov 15; 89(22):10716-20.
    View in: PubMed
  201. Pier GB, Meluleni G, Neuger E. A murine model of chronic mucosal colonization by Pseudomonas aeruginosa. Infect Immun. 1992 Nov; 60(11):4768-76.
    View in: PubMed
  202. Fleiszig SM, Efron N, Pier GB. Extended contact lens wear enhances Pseudomonas aeruginosa adherence to human corneal epithelium. Invest Ophthalmol Vis Sci. 1992 Sep; 33(10):2908-16.
    View in: PubMed
  203. Takeda S, Pier GB, Kojima Y, Tojo M, Muller E, Tosteson T, Goldmann DA. Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation. 1991 Dec; 84(6):2539-46.
    View in: PubMed
  204. Pier GB, Grout M, Desjardins D. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins. J Immunol. 1991 Sep 15; 147(6):1869-76.
    View in: PubMed
  205. Muller E, Takeda S, Goldmann DA, Pier GB. Blood proteins do not promote adherence of coagulase-negative staphylococci to biomaterials. Infect Immun. 1991 Sep; 59(9):3323-6.
    View in: PubMed
  206. Schreiber JR, Pier GB, Grout M, Nixon K, Patawaran M. Induction of opsonic antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide by an anti-idiotypic monoclonal antibody. J Infect Dis. 1991 Sep; 164(3):507-14.
    View in: PubMed
  207. Schreiber JR, Nixon KL, Tosi MF, Pier GB, Patawaran MB. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa. II. Isotype and functional activity of the anti-idiotype-induced antibodies. J Immunol. 1991 Jan 1; 146(1):188-93.
    View in: PubMed
  208. Pier GB. Vaccine potential of Pseudomonas aeruginosa mucoid exopolysaccharide (alginate). Antibiot Chemother. 1991; 44:136-42.
    View in: PubMed
  209. Markham RB, Pier GB, Schreiber JR. The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa. J Immunol. 1991 Jan 1; 146(1):316-20.
    View in: PubMed
  210. Pollack M, Tao M, Akiyama M, Pier GB, Koles NL. In vitro and in vivo functional activities of monoclonal antibodies reactive with Pseudomonas aeruginosa serogroup 6 lipopolysaccharides. Antibiot Chemother. 1991; 44:163-71.
    View in: PubMed
  211. Pier GB, Small GJ, Warren HB. Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections. Science. 1990 Aug 3; 249(4968):537-40.
    View in: PubMed
  212. Kojima Y, Tojo M, Goldmann DA, Tosteson TD, Pier GB. Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci. J Infect Dis. 1990 Aug; 162(2):435-41.
    View in: PubMed
  213. Garner CV, DesJardins D, Pier GB. Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide. Infect Immun. 1990 Jun; 58(6):1835-42.
    View in: PubMed
  214. Jones MM, Seilheimer DK, Pier GB, Rossen RD. Increased elastase secretion by peripheral blood monocytes in cystic fibrosis patients. Clin Exp Immunol. 1990 Jun; 80(3):344-9.
    View in: PubMed
  215. Schreiber JR, Patawaran M, Tosi M, Lennon J, Pier GB. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa. J Immunol. 1990 Feb 1; 144(3):1023-9.
    View in: PubMed
  216. Kocharova NA, Hatano K, Shaskov AS, Knirel YA, Kochetkov NK, Pier GB. The structure and serologic distribution of an extracellular neutral polysaccharide from Pseudomonas aeruginosa immunotype 3. J Biol Chem. 1989 Sep 15; 264(26):15569-73.
    View in: PubMed
  217. Pier GB, Pollack M. Isolation, structure, and immunogenicity of Pseudomonas aeruginosa immunotype 4 high-molecular-weight polysaccharide. Infect Immun. 1989 Feb; 57(2):426-31.
    View in: PubMed
  218. Pier GB. Immunologic properties of Pseudomonas aeruginosa mucoid exopolysaccharide (alginate). Antibiot Chemother. 1989; 42:80-7.
    View in: PubMed
  219. Garner CV, Pier GB. Immunologic considerations for the development of conjugate vaccines. Contrib Microbiol Immunol. 1989; 10:11-7.
    View in: PubMed
  220. Pier GB, Thomas D, Small G, Siadak A, Zweerink H. In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide. Infect Immun. 1989 Jan; 57(1):174-9.
    View in: PubMed
  221. Lukac M, Pier GB, Collier RJ. Toxoid of Pseudomonas aeruginosa exotoxin A generated by deletion of an active-site residue. Infect Immun. 1988 Dec; 56(12):3095-8.
    View in: PubMed
  222. Markham RB, Pier GB, Powderly WG. Suppressor T cells regulating the cell-mediated immune response to Pseudomonas aeruginosa can be generated by immunization with anti-bacterial T cells. J Immunol. 1988 Dec 1; 141(11):3975-9.
    View in: PubMed
  223. Vishwanath S, Ramphal R, Guay CM, DesJardins D, Pier GB. Respiratory-mucin inhibition of the opsonophagocytic killing of Pseudomonas aeruginosa. Infect Immun. 1988 Sep; 56(9):2218-22.
    View in: PubMed
  224. Kocharova NA, Knirel YA, Shashkov AS, Kochetkov NK, Pier GB. Structure of an extracellular cross-reactive polysaccharide from Pseudomonas aeruginosa immunotype 4. J Biol Chem. 1988 Aug 15; 263(23):11291-5.
    View in: PubMed
  225. Pier GB. Polysaccharide antigens of Pseudomonas aeruginosa. Rev Infect Dis. 1988 Jul-Aug; 10 Suppl 2:S337-40.
    View in: PubMed
  226. Zweerink HJ, Gammon MC, Hutchison CF, Jackson JJ, Pier GB, Puckett JM, Sewell TJ, Sigal NH. X-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa. Infect Immun. 1988 May; 56(5):1209-14.
    View in: PubMed
  227. Powderly WG, Schreiber JR, Pier GB, Markham RB. T cells recognizing polysaccharide-specific B cells function as contrasuppressor cells in the generation of T cell immunity to Pseudomonas aeruginosa. J Immunol. 1988 Apr 15; 140(8):2746-52.
    View in: PubMed
  228. Tojo M, Yamashita N, Goldmann DA, Pier GB. Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J Infect Dis. 1988 Apr; 157(4):713-22.
    View in: PubMed
  229. Lee JC, Perez NE, Hopkins CA, Pier GB. Purified capsular polysaccharide-induced immunity to Staphylococcus aureus infection. J Infect Dis. 1988 Apr; 157(4):723-30.
    View in: PubMed
  230. Speert DP, Dimmick JE, Pier GB, Saunders JM, Hancock RE, Kelly N. An immunohistological evaluation of Pseudomonas aeruginosa pulmonary infection in two patients with cystic fibrosis. Pediatr Res. 1987 Dec; 22(6):743-7.
    View in: PubMed
  231. Lee JC, Betley MJ, Hopkins CA, Perez NE, Pier GB. Virulence studies, in mice, of transposon-induced mutants of Staphylococcus aureus differing in capsule size. J Infect Dis. 1987 Nov; 156(5):741-50.
    View in: PubMed
  232. Pier GB, Saunders JM, Ames P, Edwards MS, Auerbach H, Goldfarb J, Speert DP, Hurwitch S. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. N Engl J Med. 1987 Sep 24; 317(13):793-8.
    View in: PubMed
  233. Lee JC, Michon F, Perez NE, Hopkins CA, Pier GB. Chemical characterization and immunogenicity of capsular polysaccharide isolated from mucoid Staphylococcus aureus. Infect Immun. 1987 Sep; 55(9):2191-7.
    View in: PubMed
  234. Parsonnet J, Gillis ZA, Richter AG, Pier GB. A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect Immun. 1987 May; 55(5):1070-6.
    View in: PubMed
  235. Powderly WG, Pier GB, Markham RB. In vitro T cell-mediated killing of Pseudomonas aeruginosa. V. Generation of bactericidal T cells in nonresponder mice. J Immunol. 1987 Apr 1; 138(7):2272-7.
    View in: PubMed
  236. Ramphal R, Guay C, Pier GB. Pseudomonas aeruginosa adhesins for tracheobronchial mucin. Infect Immun. 1987 Mar; 55(3):600-3.
    View in: PubMed
  237. Pennington JE, Pier GB. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia]. Infection. 1987 Jan-Feb; 15(1):56-9.
    View in: PubMed
  238. Pennington JE, Pier GB. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia]. Infection. 1987; 15 Suppl 2:S47-50.
    View in: PubMed
  239. Pennington JE, Small GJ, Lostrom ME, Pier GB. Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia. Infect Immun. 1986 Oct; 54(1):239-44.
    View in: PubMed
  240. Powderly WG, Pier GB, Markham RB. In vitro T cell-mediated killing of Pseudomonas aeruginosa. IV. Nonresponsiveness in polysaccharide-immunized BALB/c mice is attributable to vinblastine-sensitive suppressor T cells. J Immunol. 1986 Sep 15; 137(6):2025-30.
    View in: PubMed
  241. Stoll BJ, Pollack M, Young LS, Koles N, Gascon R, Pier GB. Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide. Infect Immun. 1986 Sep; 53(3):656-62.
    View in: PubMed
  242. Pier GB, Desjardins D, Aguilar T, Barnard M, Speert DP. Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients. J Clin Microbiol. 1986 Aug; 24(2):189-96.
    View in: PubMed
  243. Powderly WG, Pier GB, Markham RB. T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice. J Clin Invest. 1986 Aug; 78(2):375-80.
    View in: PubMed
  244. Pennington JE, Pier GB, Sadoff JC, Small GJ. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia. Rev Infect Dis. 1986 Jul-Aug; 8 Suppl 4:S426-33.
    View in: PubMed
  245. Parsonnet J, Gillis ZA, Pier GB. Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome. J Infect Dis. 1986 Jul; 154(1):55-63.
    View in: PubMed
  246. Pier GB, Bennett SE. Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide. J Clin Invest. 1986 Feb; 77(2):491-5.
    View in: PubMed
  247. Noth JM, Barza M, Forster RK, Okumoto M, Pier G, Baum J. Serotyping of ocular Pseudomonas aeruginosa clinical isolates. Cornea. 1986; 5(3):151-3.
    View in: PubMed
  248. Powderly WG, Pier GB, Markham RB. In vitro T cell-mediated killing of Pseudomonas aeruginosa. III. The role of suppressor T cells in nonresponder mice. J Immunol. 1986 Jan; 136(1):299-303.
    View in: PubMed
  249. Pier GB. Terminology relating to extracellular polysaccharides produced by Pseudomonas aeruginosa. J Infect Dis. 1985 Sep; 152(3):652.
    View in: PubMed
  250. Ames P, DesJardins D, Pier GB. Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide. Infect Immun. 1985 Aug; 49(2):281-5.
    View in: PubMed
  251. Parsonnet J, Mills JT, Gillis ZA, Pier GB. Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin 1. J Clin Microbiol. 1985 Jul; 22(1):26-31.
    View in: PubMed
  252. Markham RB, Pier GB, Goellner JJ, Mizel SB. In vitro T cell-mediated killing of Pseudomonas aeruginosa. II. The role of macrophages and T cell subsets in T cell killing. J Immunol. 1985 Jun; 134(6):4112-7.
    View in: PubMed
  253. Daley L, Pier GB, Liporace JD, Eardley DD. Polyclonal B cell stimulation and interleukin 1 induction by the mucoid exopolysaccharide of Pseudomonas aeruginosa associated with cystic fibrosis. J Immunol. 1985 May; 134(5):3089-93.
    View in: PubMed
  254. Pier GB. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. J Infect Dis. 1985 Apr; 151(4):575-80.
    View in: PubMed
  255. Parsonnet J, Hickman RK, Eardley DD, Pier GB. Induction of human interleukin-1 by toxic-shock-syndrome toxin-1. J Infect Dis. 1985 Mar; 151(3):514-22.
    View in: PubMed
  256. Pier GB. Pseudomonas aeruginosa surface polysaccharide vaccines. New therapeutic approaches from basic research. Antibiot Chemother. 1985; 36:157-67.
    View in: PubMed
  257. Ramphal R, Pier GB. Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells. Infect Immun. 1985 Jan; 47(1):1-4.
    View in: PubMed
  258. Pier GB, Ames P. Mediation of the killing of rough, mucoid isolates of Pseudomonas aeruginosa from patients with cystic fibrosis by the alternative pathway of complement. J Infect Dis. 1984 Aug; 150(2):223-8.
    View in: PubMed
  259. Markham RB, Goellner J, Pier GB. In vitro T cell-mediated killing of Pseudomonas aeruginosa. I. Evidence that a lymphokine mediates killing. J Immunol. 1984 Aug; 133(2):962-8.
    View in: PubMed
  260. Pier GB, Elcock ME. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa. J Immunol. 1984 Aug; 133(2):734-9.
    View in: PubMed
  261. Pier GB, Pollack M, Cohen M. Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 Pseudomonas aeruginosa. Infect Immun. 1984 Aug; 45(2):309-13.
    View in: PubMed
  262. Pollack M, Pier GB, Prescott RK. Immunization with Pseudomonas aeruginosa high-molecular-weight polysaccharides prevents death from Pseudomonas burn infections in mice. Infect Immun. 1984 Feb; 43(2):759-60.
    View in: PubMed
  263. Pier GB, Cohen M, Jennings H. Further purification and characterization of high-molecular-weight polysaccharide from Pseudomonas aeruginosa. Infect Immun. 1983 Dec; 42(3):936-41.
    View in: PubMed
  264. Markham RB, Pier GB. Immunologic basis for mouse protection provided by high-molecular-weight polysaccharide from immunotype 1 Pseudomonas aeruginosa. Rev Infect Dis. 1983 Nov-Dec; 5 Suppl 5:S957-62.
    View in: PubMed
  265. Pennington JE, Pier GB. Efficacy of cell wall Pseudomonas aeruginosa vaccines for protection against experimental pneumonia. Rev Infect Dis. 1983 Nov-Dec; 5 Suppl 5:S852-7.
    View in: PubMed
  266. Pier GB. Immunochemistry of Pseudomonas aeruginosa lipopolysaccharides and high-molecular-weight polysaccharides. Rev Infect Dis. 1983 Nov-Dec; 5 Suppl 5:S950-6.
    View in: PubMed
  267. Pier GB. Cystic fibrosis and Pseudomonas infections. Lancet. 1983 Oct 1; 2(8353):794.
    View in: PubMed
  268. Hancock RE, Mutharia LM, Chan L, Darveau RP, Speert DP, Pier GB. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun. 1983 Oct; 42(1):170-7.
    View in: PubMed
  269. Pier GB, Thomas DM. Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa. J Infect Dis. 1983 Aug; 148(2):206-13.
    View in: PubMed
  270. Markham RB, Pier GB. Characterization of the antibody response in inbred mice to a high-molecular-weight polysaccharide from Pseudomonas aeruginosa immunotype 1. Infect Immun. 1983 Jul; 41(1):232-6.
    View in: PubMed
  271. Pier GB, Matthews WJ, Eardley DD. Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa. J Infect Dis. 1983 Mar; 147(3):494-503.
    View in: PubMed
  272. Griffiss JM, Brandt BL, Altieri PL, Pier GB, Berman SL. Safety and immunogenicity of a group 29E meningococcal capsular polysaccharide vaccine in adults. Infect Immun. 1983 Jan; 39(1):247-52.
    View in: PubMed
  273. Pier GB. Cross-protection by Pseudomonas aeruginosa polysaccharides. Infect Immun. 1982 Dec; 38(3):1117-22.
    View in: PubMed
  274. Pier GB, Markham RB. Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine. J Immunol. 1982 May; 128(5):2121-5.
    View in: PubMed
  275. Pier GB. Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa. J Clin Invest. 1982 Feb; 69(2):303-8.
    View in: PubMed
  276. Pier GB, Thomas DM. Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of Pseudomonas aeruginosa. J Infect Dis. 1982 Feb; 145(2):217-23.
    View in: PubMed
  277. Schneider H, Griffiss JM, Williams GD, Pier GB. Immunological basis of serum resistance of Neisseria gonorrhoeae. J Gen Microbiol. 1982 Jan; 128(1):13-22.
    View in: PubMed
  278. Griffiss JM, Brandt BL, Altieri PL, Pier GB, Berman SL. Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults. Infect Immun. 1981 Dec; 34(3):725-32.
    View in: PubMed
  279. Pier GB, Sidberry HF, Sadoff JC. High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2. Infect Immun. 1981 Nov; 34(2):461-8.
    View in: PubMed
  280. Pier GB, Markham RB, Eardley D. Correlation of the biologic responses of C3H/HEJ mice to endotoxin with the chemical and structural properties of the lipopolysaccharides from Pseudomonas aeruginosa and Escherichia coli. J Immunol. 1981 Jul; 127(1):184-91.
    View in: PubMed
  281. Macone AB, Pier GB, Pennington JE, Matthews WJ, Goldmann DA. Mucoid Escherichia coli in cystic fibrosis. N Engl J Med. 1981 Jun 11; 304(24):1445-9.
    View in: PubMed
  282. Brandt BL, Pier GB, Goroff DK, Altieri PL, Griffiss JM. Elaboration of both the group W135 and group Y capsular polysccharides by a single strain of Neisseria meningitidis. J Gen Microbiol. 1980 May; 118(1):39-43.
    View in: PubMed
  283. Pier GB, Sidberry HF, Sadoff JC. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa. Infect Immun. 1978 Dec; 22(3):919-25.
    View in: PubMed
  284. Pier GB, Sidberry HF, Zolyomi S, Sadoff JC. Isolation and characterization of a high-molecular-weight polysaccharide from the slime of Pseudomonas aeruginosa. Infect Immun. 1978 Dec; 22(3):908-18.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Pier's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_